Organization · Venture Capital
CD Capital
CD Capital is a venture capital firm based in Shanghai, specializing in investments in the medical technology and life sciences sectors. The firm manages over $1.4 billion in assets and has backed more than 90 companies in the healthcare industry.
Overview
What CD Capital does
What CD Capital is
CD Capital is a venture capital firm based in Shanghai, specializing in investments in the medical technology and life sciences sectors. The firm manages over $1.4 billion in assets and has backed more than 90 companies in the healthcare industry.
How it participates in the startup ecosystem
The current public profile supports funder and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder · Event host
- Last reviewed
- March 27, 2026
Official channels
Find CD Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
CD Capital as a funder
Investment thesis
CD Capital focuses on identifying and supporting high-potential enterprises in the healthcare industry, particularly in medical technology and life sciences. The firm leverages extensive resources and research capabilities within the Chinese healthcare sector to drive growth and innovation.
Focus narrative
CD Capital primarily invests in the medical technology and life sciences sectors, seeking opportunities driven by technological innovation. The firm emphasizes a structured post-investment support system to empower entrepreneurs and enhance the growth potential of its portfolio companies.
Value beyond capital
CD Capital adds value to its portfolio companies through a structured post-investment support system, leveraging its extensive network and resources within the healthcare industry to drive growth and innovation.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Regions
- Asia · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 90
- Recorded notable exits
- Aidite
Portfolio context
CD Capital has invested in over 90 companies, including notable firms such as Urotronic, which focuses on innovative medical devices; iRay Technology, specializing in advanced imaging technologies; and BMC Medical, engaged in medical device development. Other portfolio companies include SprintRay Inc, known for 3D printing solutions for dental applications, and Surgerii Robotics, which develops robotic solutions for surgical procedures.
Capability profile
CD Capital as an event host
Event focus
CD Capital focuses on the healthcare sector, particularly in medical technology and life sciences. The firm aims to identify and invest in high-potential enterprises that can become industry leaders, leveraging its extensive industry resources and research capabilities.
Format narrative
CD Capital hosts an annual meeting and industry forum, focusing on themes of integrity and innovation within the investment landscape.
Participant value
CD Capital aims to create a sustainable industrial ecosystem through collaboration with entrepreneurs, emphasizing technological innovation in healthcare.
Format and cadence
- Event types
- summit
- Recurrence
- annual
- Modality
- in-person
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
- Next event location
- Shanghai
Audience and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Audience
- Founders · Investors
- Regions
- Asia
Speakers and past editions
Past editions
The most recent event was successfully held in Shanghai in October 2023.
Common questions
What to know about CD Capital
Upseed classifies CD Capital under the Venture Capital organization type. Its current public profile includes funder and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.